Novel Pharmacokinetic-Pharmacodynamic Model for Prediction of Outcomes with an Extended-Release Formulation of Ciprofloxacin

Por Meagher, Alison K., Forrest, Alan, Dalhoff, Axel, Stass, Heino, Schentag, Jerome J.
Publicado em 2004

Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study

Por Stass, Heino, Nagelschmitz, Johannes, Willmann, Stefan, Delesen, Heinz, Gupta, Abhishek, Baumann, Sybille
Publicado em 2013

Penetration of Moxifloxacin into Peripheral Compartments in Humans

Por Müller, Markus, Staß, Heino, Brunner, Martin, Möller, Jan G., Lackner, Edith, Eichler, Hans G.
Publicado em 1999

Penetration of Moxifloxacin into Healthy and Inflamed Subcutaneous Adipose Tissues in Humans

Por Joukhadar, Christian, Stass, Heino, Müller-Zellenberg, Ulrike, Lackner, Edith, Kovar, Florian, Minar, Erich, Müller, Markus
Publicado em 2003

A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life

Por Schlender, Jan-Frederik, Teutonico, Donato, Coboeken, Katrin, Schnizler, Katrin, Eissing, Thomas, Willmann, Stefan, Jaehde, Ulrich, Stass, Heino
Publicado no Clin Pharmacokinet (2018)